IGF2 and endometrial carcinoma: While the increase of IGF2 in Herceptin resistant cells was attributed to the decrease of miR-193a-5p via inactivation of FOXO3a, this miRNA was shown to be involved in tumorigenesis of endometrial carcinoma through directly targeting YY143.